Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Viasat
VSAT
$11.9B
| $1.1M | ﹤0.01% |
32,383
+7,812
| +32% | +$267K |
|
|
DNB
2602
DELISTED
Dun & Bradstreet
DNB
| $1.09M | ﹤0.01% |
93,145
-206,730
| -69% | -$2.62M |
|
2603
Fomento Económico Mexicano
FMX
$42.8B
| $1.09M | ﹤0.01% |
11,487
+1,333
| +13% | +$117K |
|
2604
Ceco Environmental
CECO
$4.1B
| $1.09M | ﹤0.01% |
78,131
+29,628
| +61% | +$419K |
|
2605
Orion
OEC
$385M
| $1.09M | ﹤0.01% |
41,889
+25,644
| +158% | +$580K |
|
|
ROIC
2606
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.09M | ﹤0.01% |
78,011
-306,282
| -80% | -$4.45M |
|
|
VSTO
2607
DELISTED
Vista Outdoor Inc.
VSTO
| $1.09M | ﹤0.01% |
39,214
+5,194
| +15% | +$142K |
|
|
MNTN
2608
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $1.09M | ﹤0.01% |
103,880
| – | – |
|
2609
Tanger
SKT
$4.68B
| $1.09M | ﹤0.01% |
55,346
-32,151
| -37% | -$597K |
|
2610
Ligand Pharmaceuticals
LGND
$5.85B
| $1.09M | ﹤0.01% |
14,768
-22,555
| -60% | -$1.6M |
|
2611
Laureate Education
LAUR
$5.18B
| $1.09M | ﹤0.01% |
92,353
-9,058
| -9% | -$99.7K |
|
|
BBBY
2612
Bed Bath & Beyond
BBBY
$507M
| $1.08M | ﹤0.01% |
58,869
+11,215
| +24% | +$209K |
|
|
KW
2613
DELISTED
Kennedy-Wilson Holdings
KW
| $1.08M | ﹤0.01% |
65,253
+21,043
| +48% | +$358K |
|
2614
Acushnet Holdings
GOLF
$5.98B
| $1.08M | ﹤0.01% |
21,197
+12,257
| +137% | +$595K |
|
|
ZUO
2615
DELISTED
Zuora, Inc.
ZUO
| $1.08M | ﹤0.01% |
109,114
+28,789
| +36% | +$241K |
|
2616
Coeur Mining
CDE
$16.7B
| $1.08M | ﹤0.01% |
269,726
+87,871
| +48% | +$305K |
|
|
NOAH
2617
Noah Holdings
NOAH
$584M
| $1.07M | ﹤0.01% |
64,782
-78,183
| -55% | -$1.45M |
|
2618
Cohen & Steers
CNS
$4.35B
| $1.07M | ﹤0.01% |
16,716
+6,676
| +66% | +$466K |
|
|
AVNS
2619
DELISTED
Avanos Medical
AVNS
| $1.07M | ﹤0.01% |
35,912
+6,037
| +20% | +$175K |
|
|
GES
2620
DELISTED
Guess Inc
GES
| $1.07M | ﹤0.01% |
54,845
+5,424
| +11% | +$116K |
|
|
HTO
2621
H2O America
HTO
$2.6B
| $1.07M | ﹤0.01% |
13,999
+1,006
| +8% | +$77.7K |
|
2622
Adeia
ADEA
$3.44B
| $1.06M | ﹤0.01% |
120,025
-394,767
| -77% | -$3.95M |
|
2623
Enanta Pharmaceuticals
ENTA
$377M
| $1.06M | ﹤0.01% |
26,250
-24,649
| -48% | -$1.18M |
|
|
VBTX
2624
DELISTED
Veritex Holdings
VBTX
| $1.06M | ﹤0.01% |
57,983
+20,539
| +55% | +$524K |
|
2625
S&T Bancorp
STBA
$1.85B
| $1.06M | ﹤0.01% |
33,644
+9,667
| +40% | +$337K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.